March 27, 2026 – Medtronic declares U.S. Meals and Drug Administration (FDA) approval of the Stealth AXiS™ Surgical System for cranial, ear, nostril and throat (ENT) procedures. Launched in February for backbone procedures, the Stealth AXiS™ Surgical System unifies surgical planning, navigation and robotics in a single clever system to help surgeons with higher precision and real-time insights throughout complicated procedures. This approval reinforces Medtronic’s technique to ship related applied sciences that help surgeons in a number of specialties on a single platform.

A defining functionality of the platform is its AI-based structure, which helps superior planning and visualization earlier than, throughout and after surgical procedure. For cranial procedures, the system consists of AI-based automated tractography that permits surgeons to generate patient-specific mind maps and visualize crucial neural pathways related to important mind features. The platform additionally integrates intraoperative ultrasound by means of GE HealthCare’s bkActiv™, offering further real-time imaging throughout procedures.

Proceed studying